213 related articles for article (PubMed ID: 26408804)
21. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
22. Shortened telomere length in hepatocellular carcinomas and corresponding background liver tissues of patients infected with hepatitis virus.
Ohashi K; Tsutsumi M; Kobitsu K; Fukuda T; Tsujiuchi T; Okajima E; Ko S; Nakajima Y; Nakano H; Konishi Y
Jpn J Cancer Res; 1996 May; 87(5):419-22. PubMed ID: 8641975
[TBL] [Abstract][Full Text] [Related]
23. Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme.
Kubo N; Morita M; Nakashima Y; Kitao H; Egashira A; Saeki H; Oki E; Kakeji Y; Oda Y; Maehara Y
Dis Esophagus; 2014 Apr; 27(3):285-93. PubMed ID: 23902537
[TBL] [Abstract][Full Text] [Related]
24. The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinoma.
Gwak GY; Lee DH; Moon TG; Choi MS; Lee JH; Koh KC; Paik SW; Park CK; Joh JW; Yoo BC
Hepatogastroenterology; 2008; 55(88):2028-32. PubMed ID: 19260471
[TBL] [Abstract][Full Text] [Related]
25. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
26. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
Zhang X; Dong N; Zhang H; You J; Wang H; Ye L
J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653
[TBL] [Abstract][Full Text] [Related]
27. Telomere length, telomerase expression, and oxidative stress in lead smelters.
Pawlas N; Płachetka A; Kozłowska A; Mikołajczyk A; Kasperczyk A; Dobrakowski M; Kasperczyk S
Toxicol Ind Health; 2016 Dec; 32(12):1961-1970. PubMed ID: 26381690
[TBL] [Abstract][Full Text] [Related]
28. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
31. [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
Koike K
Nihon Rinsho; 1999 Jan; 57(1):213-9. PubMed ID: 10036965
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
33. Molecular aspects of hepatic carcinogenesis.
Nita ME; Alves VA; Carrilho FJ; Ono-Nita SK; Mello ES; Gama-Rodrigues JJ
Rev Inst Med Trop Sao Paulo; 2002; 44(1):39-48. PubMed ID: 11896411
[TBL] [Abstract][Full Text] [Related]
34. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
Cevik D; Yildiz G; Ozturk M
World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
[TBL] [Abstract][Full Text] [Related]
35. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
[TBL] [Abstract][Full Text] [Related]
36. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL
Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256
[TBL] [Abstract][Full Text] [Related]
38. Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in Long-Evans Cinnamon rats.
Tsubota A; Yoshikawa T; Nariai K; Mitsunaga M; Yumoto Y; Fukushima K; Hoshina S; Fujise K
J Hepatol; 2008 Mar; 48(3):486-93. PubMed ID: 18191270
[TBL] [Abstract][Full Text] [Related]
39. Sex-dependent telomere shortening, telomerase activity and oxidative damage in marine medaka Oryzias melastigma during aging.
Yip BW; Mok HO; Peterson DR; Wan MT; Taniguchi Y; Ge W; Au DW
Mar Pollut Bull; 2017 Nov; 124(2):701-709. PubMed ID: 28129920
[TBL] [Abstract][Full Text] [Related]
40. TERT promoter mutations and telomeres during tumorigenesis.
Lorbeer FK; Hockemeyer D
Curr Opin Genet Dev; 2020 Feb; 60():56-62. PubMed ID: 32163830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
